CHRISTOPHER MARTIN: Open Payments
NPI 1134122955 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,880 in 96 payments from 16 companies in 2025. Trend: 2023 $462 · 2024 $239 · 2025 $1,880
Food & beverage: $1,880
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 22 | $323 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $234 |
| Neurocrine BioSciences, Inc. | 7 | $214 |
| Lundbeck LLC | 14 | $200 |
| Teva Pharmaceuticals USA, Inc. | 7 | $162 |
| Collegium Pharmaceutical, Inc. | 7 | $129 |
| Bausch Health US, LLC | 4 | $92 |
| Janssen Pharmaceuticals, Inc | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Axsome Therapeutics, Inc. | 3 | $82 |
Products named: REXULTI, CAPLYTA, INGREZZA, AUSTEDO XR, Jornay PM, SPRAVATO, Auvelity, TRINTELLIX.
Industry payments across NY — which companies pay providers there.
